Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04303858
Title A Study to Evaluate Safety and Anti-Tumor Activity of RO7284755 Alone or in Combination With Atezolizumab in Participants With Advanced and/or Metastatic Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult | senior
Covered Countries POL | NLD | ESP | DNK | CAN | BEL

Facility Status City State Zip Country Details
Cliniques Universitaires St-Luc Bruxelles 1200 Belgium Details
UZ Leuven Gasthuisberg Leuven 3000 Belgium Details
Princess Margaret Cancer Center Toronto Ontario M5G 2M9 Canada Details
Herlev Hospital; Afdeling for Kræftbehandling Herlev 2730 Denmark Details
Rigshospitalet; Fase 1 Enhed - Onkologi København Ø 2100 Denmark Details
NKI/AvL Amsterdam 1066 CX Netherlands Details
Erasmus MC Rotterdam 3015 GD Netherlands Details
Uniwersyteckie Centrum Kliniczne; Osrodek Badan Wczesnych Faz Gda?sk 80-214 Poland Details
Narodowy Instytut Onkologii im. M. Sklodowskiej-Curie; Oddzial Badan Wczesnych Faz Warszawa 02-781 Poland Details
Clinica Universitaria de Navarra; Servicio de Oncologia Pamplona Navarra 31008 Spain Details
Hospital del Mar; Servicio de Oncologia Barcelona 08003 Spain Details
Vall d?Hebron Institute of Oncology (VHIO), Barcelona Barcelona 08035 Spain Details
Hospital Clinic Barcelona; Servicio de oncologia Barcelona 08036 Spain Details
Clinica Universidad de Navarra Madrid; Servicio de Oncología Madrid 28027 Spain Details
START Madrid-FJD, Hospital Fundacion Jimenez Diaz Madrid 28040 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field